Results 11 to 20 of about 445,273 (266)

Comorbidities in interstitial lung diseases

open access: yesEuropean Respiratory Review, 2017
Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted.
George A. Margaritopoulos   +2 more
doaj   +1 more source

Interstitial cystitis

open access: yesJournal of Obstetrics and Gynaecology, 2004
Interstitial cystitis (IC) is a debilitating chronic inflammatory disorder of the bladder. It affects predominantly middle-aged Caucasian women. The diagnosis, made from the combination of symptoms, cystoscopic findings and bladder biopsies, is often delayed in the gynaecology setting because of a low index of suspicion.
D O, Selo-Ojeme, J L, Onwude
openaire   +2 more sources

Multimodal therapy for painful bladder syndrome / interstitial cystitis: pilot study combining behavioral, pharmacologic, and endoscopic therapies

open access: yesInternational Brazilian Journal of Urology, 2009
Purpose: We evaluated the effectiveness of combining behavioral therapy, pharmacologic therapy and endoscopic hydrodistension for treating painful bladder syndrome / interstitial cystitis (PBS/IC).
Robert S. Hanley   +4 more
doaj   +1 more source

Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality

open access: yesERJ Open Research
Background Overnight desaturation predicts poor prognosis across interstitial lung diseases (ILDs). The aim of the present study was to investigate whether nocturnal desaturation is associated with pulmonary vasculopathy and mortality.
George A. Margaritopoulos   +13 more
doaj   +1 more source

Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology

open access: yesRespiratory Research, 2023
Introduction Interstitial lung disease (ILD) may be difficult to distinguish from other respiratory diseases due to overlapping clinical presentation. Recognition of ILD is often late, causing delay which has been associated with worse clinical outcome ...
Iris G. van der Sar   +6 more
doaj   +1 more source

Erasmus Syndrome—A Rare Cause of Diffuse Cutaneous Systemic Sclerosis due to Silica Exposure: A Case Report [PDF]

open access: yesBengal Physician Journal
Erasmus syndrome is a rare disease characterized by the development of systemic sclerosis (SSc) in the background of silica exposure or silicosis. Here we report a case of a 42-year-old male who presented with skin tightening for 2 years and progressive ...
Shankar Dey   +5 more
doaj   +1 more source

Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT

open access: yesDiagnostics, 2020
To evaluate the radiological findings in patients with cryptogenic organizing pneumonia (COP) before steroid treatment and their behavior after therapy, we retrospectively evaluated a total of 22 patients with a diagnosis of COP made by bronchoalveolar ...
Francesco Tiralongo   +13 more
doaj   +1 more source

Predictors and changes of physical activity in idiopathic pulmonary fibrosis

open access: yesBMC Pulmonary Medicine, 2022
Background Different clinical predictors of physical activity (PA) have been described in idiopathic pulmonary fibrosis (IPF), but studies are lacking evaluating the potential role of muscle strength and anxiety and depression symptoms in PA limitation ...
Diana Badenes-Bonet   +15 more
doaj   +1 more source

Evolving Concepts in Progressive Pulmonary Fibrosis: A Clinical Update

open access: yesJournal of Respiration
Progressive pulmonary fibrosis (PPF) is a clinical syndrome associated with worsening quality of life and increased mortality among patients with various interstitial lung diseases.
María Belén Noboa-Sevilla   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy